Gauri Wechalekar
YOU?
Author Swipe
View article: Validation of the 5th edition of the World Health Organization and International Consensus Classification guidelines for TP53-mutated myeloid neoplasm in an independent international cohort
Validation of the 5th edition of the World Health Organization and International Consensus Classification guidelines for TP53-mutated myeloid neoplasm in an independent international cohort Open
The World Health Organization (WHO-5) and International Consensus Classification (ICC) acknowledge the poor prognosis of TP53 -mutated ( TP53 mut ) myeloid neoplasm (MN). However, there are substantial differences between the two classific…
View article: Clonal Architecture of Donor-Derived Leukemia/Clonal Hematopoiesis after Allogeneic Hematopoietic Stem Cell Transplant
Clonal Architecture of Donor-Derived Leukemia/Clonal Hematopoiesis after Allogeneic Hematopoietic Stem Cell Transplant Open
BACKGROUND Donor derived leukemia (DDL) is a rare complication of allogeneic hematopoietic stem cell transplant (alloHSCT) with reported incidence ranging from 0.08% to 0.84% and median time to diagnosis 17 to 48 months post-alloHSCT (Aldo…